pyridostigmine bromide has been researched along with Thyroid Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rezania, K; Soliven, B; Yuen, C | 1 |
| Claussen, GC; Kim, DS; Kwon, KH; Mussell, H; Oh, SJ; Tseng, A | 1 |
2 other study(ies) available for pyridostigmine bromide and Thyroid Neoplasms
| Article | Year |
|---|---|
ATM mutation in a patient with thymoma-associated myasthenia gravis.
Topics: Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Carcinoma, Ductal, Breast; Cholinesterase Inhibitors; Female; Glucocorticoids; Heterozygote; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Iodine Radioisotopes; Jews; Middle Aged; Mutation; Myasthenia Gravis; Neoplasms, Multiple Primary; Neoplastic Syndromes, Hereditary; Prednisone; Pyridostigmine Bromide; Thymectomy; Thymoma; Thymus Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy | 2020 |
Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Adult; Aged; Amifampridine; Carcinoma, Small Cell; Female; Guanidine; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Parasympathomimetics; Potassium Channel Blockers; Pyridostigmine Bromide; Retrospective Studies; Thyroid Neoplasms | 1998 |